Partek signs distribution agreement with Life Technologies

NewsGuard 100/100 Score

Partek Incorporated, a global leader in bioinformatics software, announced today the signing of a distribution agreement with Life Technologies Corporation (NASDAQ: LIFE), a provider of next-generation DNA sequencing technology. The agreement makes Partek Genomics Suite available through Life Technologies as a featured solution for analyzing data generated by Life Technologies' next-generation sequencing (NGS) devices.

“Partek has worked closely with us to ensure seamless data integration and rapid analysis, enabling our customers to interpret and present their findings with unprecedented speed and ease.”

"Partek Genomics Suite, with its intuitive workflows designed for biologists, powerful statistical analysis tools and high-quality graphical outputs, is a terrific addition to our range of data processing and analysis solutions," said Claude Benchimol, Senior Vice President of Biological Information Systems at Life Technologies. "Partek has worked closely with us to ensure seamless data integration and rapid analysis, enabling our customers to interpret and present their findings with unprecedented speed and ease."

Partek Genomics Suite is a comprehensive solution for the analysis, comparison and integration of massive amounts of genomic data. Used by thousands of scientists worldwide, Partek Genomics Suite was cited in more than one peer-reviewed publication per day in 2010. It is unique in its ability to support all microarray and NGS technologies for RNA-, DNA- and gene regulation applications in a single software package, allowing also for the integration of multiple applications in a user-friendly way. Embedded tools for alignment, quality control analysis, robust statistics, clustering, biological interpretation with functional classes and pathways helps scientists identify biomarkers and patterns in the data with confidence.

"We're excited about our partnership with Life Technologies, a globally recognized leader in biotechnology," said Tom Downey, President of Partek. "Collaborating with Life Technologies helps keep Partek on the forefront of developing software that streamlines and simplifies genomic data analysis."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Tiny DNA circles are key drivers of cancer formation, study suggests